Skip to content

Comparative study for the effects of robotic, laparoscopic and open surgery on clinical outcomes and quality of life after hepatectomy for hepatocellular carcinoma: A Perspective Randomized Controlled Trial

To explore the effect of robotic hepatectomy on the clinical outcomes and quality of life for patients with hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020979
Enrollment
Unknown
Registered
2019-01-23
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Interventions

Open liver resection:Open liver resection Patients will be performed open liver resection for HCC
Laparoscopic liver resection:Laparoscopic liver resection Patients will be performed laparoscopic liver resection for HCC
Robotic liver resection:Robotic liver resection Patients will be performed robotic liver resection for HCC

Sponsors

The First Affiliated Hospital of Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years, male or female; 2. Liver solid tumor, with clinical diagnosis of hepatocellular carcinoma; 3. Normal indocyanine green retention rate at 15min; 4. Adequate liver remnant; 5. Radical hepatectomy according to Chinese Guidelines for diagnosis and treatment of primary liver cancer (2017 Edition); 6. Child-Pugh classification of A to B; 7. No other antitumor therapy and immunotherapy before surgery; 8. No other malignant tumor history; 9. American Society of Anesthesiologists (ASA) grading of I to III 10. Body mass index of between 18 and 35; 11. Able to understand the nature of the study and what will be required of them; 12. Willingness to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Active hepatitis; 3. Recurrent HCC; 4. Other situations not suitable for this study.

Design outcomes

Primary

MeasureTime frame
recurrence rate after operation;Quality of Life;

Secondary

MeasureTime frame
Surgical margins;Time to functional recovery;Intraoperative parameters including operation time, pneumoperitoneum time, liver resection time, estimated blood loss, transfusion, as well as number, size and location of the tumor;Postoperative hospital stay;Morbidity and mortality;Hospital costs;

Countries

China

Contacts

Public ContactHe Songqing

The First Affiliated Hospital of Guangxi Medical University

dr_hesongqing@163.com+86 18978384990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026